Jason Schense
13Patents
7h-index
12Co-inventors
59Inventor score
Filing activity: Apr 8, 1998 → Sep 7, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6331422A | Enzyme-mediated modification of fibrin for tissue engineering | Chemistry; Metallurgy | 37 | Expired |
| US7241730B2 | Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides | Chemistry; Metallurgy | 20 | Expired |
| US6960452B2 | Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins | Chemistry; Metallurgy | 15 | Expired |
| US7247609B2 | Growth factor modified protein matrices for tissue engineering | Chemistry; Metallurgy | 13 | Expired |
| US6468731B1 | Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins | Chemistry; Metallurgy | 11 | Expired |
| US6894022B1 | Growth factor modified protein matrices for tissue engineering | Chemistry; Metallurgy | 11 | Expired |
| US8575101B2 | Supplemented matrices for the repair of bone fractures | Chemistry; Metallurgy | 10 | Active |
| US6607740B1 | Enzyme-mediated modification of fivrin for tissue engineering | Chemistry; Metallurgy | 6 | Expired |
| US7601685B2 | Growth factor modified protein matrices for tissue engineering | Chemistry; Metallurgy | 4 | Expired |
| US8318674B2 | Local treatment of bone defects | Human Necessities | 2 | Expired |
| US8034618B2 | PTH containing cell growth matrix | Chemistry; Metallurgy | 1 | Active |
| US10589001B2 | Pharmaceutical formulation for use in spinal fusion | Human Necessities | 1 | Active |
| US8309518B2 | Drug delivery matrices to enhance wound healing | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.